漢王科技(002362.SZ):金秋10月,預計會有漢王天地大模型及B端、C端的更多重磅新品發佈
格隆匯6月21日丨漢王科技(002362.SZ)近期在業績説明會上表示,作為人工智能的先行者,在數字化變革的進程中,一路走來,漢王用科技創新為數字中國建設注入重要力量。實現了一個又一個從0到1的突破,引爆了人工智能的各大風口。每年漢王科技的新品發佈會分為春季、秋季兩大場。今年上半年,在漢王品牌30週年之際,漢王發佈了AI電紙學習本、漢王掃描王app、掌紋識別機、PKGun圖像識別電子槍等新品;6月份,又陸續發佈了clear 7英寸電紙書、漢王親筆信,金秋10月,預計會有漢王天地大模型(暫定名)及B端、C端的更多重磅新品發佈,具體情況屆時公司會提前公吿。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.